The Current Ratio of Cellular Biomedicine Group Inc (CBMG) is
1.44.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2019-12-31 |
1.44
|
| 2018-12-31 |
6.79
|
| 2017-12-31 |
6.47
|
| 2016-12-31 |
17.21
|
| 2015-12-31 |
5.53
|
| 2014-12-31 |
3.95
|
| 2013-12-31 |
3.45
|
| 2012-12-31 |
7.17
|
| 2011-12-31 |
0.30
|
| 2010-12-31 |
-
|
| Ticker |
Name |
Value |
|
OCX
|
OncoCyte Corp
|
1.62
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
AGLE
|
Aeglea Bio Therapeutics Inc
|
4.24
|
|
CRDF
|
Cardiff Oncology, Inc.
|
3.67
|
|
LCTX
|
Lineage Cell Therapeutics Inc
|
5.20
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
SNSE
|
Sensei Biotherapeutics Inc
|
5.06
|
|
TRVN
|
Trevena Inc
|
4.66
|
|
ABUS
|
Arbutus Biopharma Corp
|
15.73
|
|
CMPI
|
Checkmate Pharmaceuticals Inc
|
7.89
|
|
VKTX
|
Viking Therapeutics, Inc.
|
9.33
|
|
VTGN
|
Vistagen Therapeutics, Inc.
|
3.67
|
|
UBX
|
Unity Biotechnology Inc
|
2.62
|
|
EIGR
|
Eiger BioPharmaceuticals Inc
|
0.71
|
|
FBRX
|
Forte Biosciences, Inc.
|
3.88
|
|
PRQR
|
ProQR Therapeutics NV
|
3.09
|
|
TYME
|
Tyme Technologies Inc
|
10.68
|
|
IBIO
|
iBio Inc
|
1.22
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
BLU.TO
|
BELLUS Health Inc
|
22.42
|
|
NCNA
|
NuCana PLC
|
5.60
|
|
SPRB
|
Spruce Biosciences, Inc.
|
5.17
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
APS.TO
|
Aptose Biosciences Inc
|
0.78
|
|
CUE
|
Cue Biopharma, Inc.
|
2.74
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
IMNM
|
Immunome, Inc.
|
14.69
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
BYSI
|
Beyondspring Inc
|
1.54
|
|
DBTX
|
Decibel Therapeutics Inc
|
4.81
|
|
KZR
|
Kezar Life Sciences, Inc.
|
11.52
|
|
ONCR
|
Oncorus Inc
|
1.74
|
|
ONCT
|
Oncternal Therapeutics Inc
|
6.94
|